Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research
Authors
Keywords
-
Journal
JOURNAL OF BONE AND MINERAL RESEARCH
Volume 31, Issue 1, Pages 16-35
Publisher
Wiley
Online
2015-09-09
DOI
10.1002/jbmr.2708
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review
- (2015) R. Fliefel et al. INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- The Effect of 6 versus 9 Years of Zoledronic Acid Treatment in Osteoporosis: A Randomized Second Extension to the HORIZON-Pivotal Fracture Trial (PFT)
- (2015) Dennis M. Black et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Atypical fracture of the femur in a patient using denosumab – a case report
- (2014) Jörg Schilcher et al. Acta Orthopaedica
- Comparative Effectiveness of Pharmacologic Treatments to Prevent Fractures
- (2014) Carolyn J. Crandall et al. ANNALS OF INTERNAL MEDICINE
- Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12
- (2014) M. Gnant et al. ANNALS OF ONCOLOGY
- Sequential treatment with teriparatide and strontium ranelate in a postmenopausal woman with atypical femoral fractures after long-term bisphosphonate administration
- (2014) Kalliopi Lampropoulou-Adamidou et al. Hormones-International Journal of Endocrinology and Metabolism
- Potential pathogenic mechanism for stress fractures of the bowed femoral shaft in the elderly: Mechanical analysis by the CT-based finite element method
- (2014) Yoto Oh et al. INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
- Association of Atypical Femoral Fractures with Bisphosphonate Use by Patients with Varus Hip Geometry
- (2014) Jennifer E Hagen et al. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
- Atypical femoral fracture in a patient treated with denosumab
- (2014) Kareeann Sok Fun Khow et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus
- (2014) Aliya A Khan et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The Risk of Osteonecrosis of the Jaws in Taiwanese Osteoporotic Patients Treated With Oral Alendronate or Raloxifene
- (2014) Wei-Yih Chiu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Reassessment of Fracture Risk in Women After 3 Years of Treatment With Zoledronic Acid: When is it Reasonable to Discontinue Treatment?
- (2014) Felicia Cosman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Framework for Crafting Clinical Practice Guidelines that are Relevant to the Care and Management of People with Multimorbidity
- (2014) Katrin Uhlig et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis
- (2014) John W. Hellstein et al. JOURNAL OF THE AMERICAN DENTAL ASSOCIATION
- Myocardial Infarction Risk Among Patients With Fractures Receiving Bisphosphonates
- (2014) Cory B. Pittman et al. MAYO CLINIC PROCEEDINGS
- Geographic and ethnic disparities in osteoporotic fractures
- (2014) Jane A. Cauley et al. Nature Reviews Endocrinology
- Risk of Atypical Femoral Fracture during and after Bisphosphonate Use
- (2014) Jörg Schilcher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Factors associated with bisphosphonate treatment failure in postmenopausal women with primary osteoporosis
- (2014) E. Cairoli et al. OSTEOPOROSIS INTERNATIONAL
- Implications of expanding indications for drug treatment to prevent fracture in older men in United States: cross sectional and longitudinal analysis of prospective cohort study
- (2014) K. E. Ensrud et al. BMJ-British Medical Journal
- Effect of Bisphosphonate Use on Risk of Postmenopausal Breast Cancer
- (2014) Trisha F. Hue et al. JAMA Internal Medicine
- Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: Efficacy and safety results from a randomized open-label study
- (2013) C. Roux et al. BONE
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Postmenopausal Osteoporosis: Executive Summary of Recommendations
- (2013) Nelson Watts et al. Endocrine Practice
- A Case of an Unusual Subtrochanteric Fracture in a Patient Receiving Denosumab
- (2013) Rodis Paparodis et al. Endocrine Practice
- Bisphosphonates and Nonhealing Femoral Fractures: Analysis of the FDA Adverse Event Reporting System (FAERS) and International Safety Efforts
- (2013) Beatrice J Edwards et al. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
- BMD changes and predictors of increased bone loss in postmenopausal women after a 5-year course of alendronate
- (2013) Brian Louis McNabb et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Renal safety in patients treated with bisphosphonates for osteoporosis: A review
- (2013) Paul D Miller et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research
- (2013) Elizabeth Shane et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Can Change in FRAX Score Be Used to “Treat to Target”? A Population-Based Cohort Study
- (2013) William D Leslie et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013
- (2013) J. Compston et al. MATURITAS
- Denosumab Compared With Ibandronate in Postmenopausal Women Previously Treated With Bisphosphonate Therapy
- (2013) Chris Recknor et al. OBSTETRICS AND GYNECOLOGY
- The non-interventional BonViva Intravenous Versus Alendronate (VIVA) study: real-world adherence and persistence to medication, efficacy, and safety, in patients with postmenopausal osteoporosis
- (2013) P. Hadji et al. OSTEOPOROSIS INTERNATIONAL
- Long-term fracture rates seen with continued ibandronate treatment: pooled analysis of DIVA and MOBILE long-term extension studies
- (2013) P. D. Miller et al. OSTEOPOROSIS INTERNATIONAL
- Comparison between various fracture risk assessment tools
- (2013) W. D. Leslie et al. OSTEOPOROSIS INTERNATIONAL
- Safety issues with bisphosphonate therapy for osteoporosis
- (2013) E. Suresh et al. RHEUMATOLOGY
- Bisphosphonate Therapy, Death, and Cardiovascular Events Among Female Patients With CKD: A Retrospective Cohort Study
- (2012) James E. Hartle et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Evidence for safety and efficacy of risedronate in men with osteoporosis over 4years of treatment: Results from the 2-year, open-label, extension study of a 2-year, randomized, double-blind, placebo-controlled study
- (2012) Steven Boonen et al. BONE
- Intensive treatment and treatment holiday of TNF-inhibitors in rheumatoid arthritis
- (2012) Yoshiya Tanaka CURRENT OPINION IN RHEUMATOLOGY
- Does osteoporosis therapy invalidate FRAX for fracture prediction?
- (2012) William D Leslie et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention
- (2012) John A Eisman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Incidence of atypical nontraumatic diaphyseal fractures of the femur
- (2012) Richard M Dell et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Atypical Femur Fractures: 81 Individual Personal Histories
- (2012) Jennifer P. Schneider et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Comparative Effectiveness of Drug Treatments to Prevent Fragility Fractures: A Systematic Review and Network Meta-Analysis
- (2012) Mohammad Hassan Murad et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Bisphosphonates for Osteoporosis — Where Do We Go from Here?
- (2012) Marcea Whitaker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis
- (2012) Steven Boonen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adherence with bisphosphonate therapy and change in bone mineral density among women with osteoporosis or osteopenia in clinical practice
- (2012) D. Weycker et al. OSTEOPOROSIS INTERNATIONAL
- The 25(OH)D level needed to maintain a favorable bisphosphonate response is ≥33 ng/ml
- (2012) A. S. Carmel et al. OSTEOPOROSIS INTERNATIONAL
- A population-based 2-year follow-up study on the relationship between bisphosphonates and the risk of stroke
- (2012) J.-H. Kang et al. OSTEOPOROSIS INTERNATIONAL
- A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis
- (2012) S. Lekamwasam et al. OSTEOPOROSIS INTERNATIONAL
- Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate—Danish National Register Based Cohort Study
- (2012) M. Pazianas et al. OSTEOPOROSIS INTERNATIONAL
- Incidence of osteonecrosis of the jaw among users of bisphosphonates with selected cancers or osteoporosis
- (2012) Patricia Tennis et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Atypical subtrochanteric femoral shaft fractures: role for mechanics and bone quality
- (2012) Marjolein CH van der Meulen et al. ARTHRITIS RESEARCH & THERAPY
- Antiresorptives and Osteonecrosis of the Jaw
- (2012) Junro Yamashita et al. Journal of Evidence-Based Dental Practice
- Prolonged bisphosphonate release after treatment in women with osteoporosis. Relationship with bone turnover
- (2011) P. Peris et al. BONE
- The relationship between the chemistry and biological activity of the bisphosphonates
- (2011) Frank H. Ebetino et al. BONE
- Use of Bisphosphonates and Risk of Breast Cancer
- (2011) Peter Vestergaard et al. CALCIFIED TISSUE INTERNATIONAL
- Bone turnover markers and bone mineral density response with risedronate therapy: Relationship with fracture risk and patient adherence
- (2011) Richard Eastell et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Esophageal and gastric cancer incidence and mortality in alendronate users
- (2011) Bo Abrahamsen et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)
- (2011) Dennis M Black et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Osteoporosis Medication and Reduced Mortality Risk in Elderly Women and Men
- (2011) Jacqueline R. Center et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Atypical Femoral Fractures during Prolonged Use of Bisphosphonates: Short-Term Responses to Strontium Ranelate and Teriparatide
- (2011) N. N. C. Carvalho et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Bisphosphonate Use and Atypical Fractures of the Femoral Shaft
- (2011) Jörg Schilcher et al. NEW ENGLAND JOURNAL OF MEDICINE
- The cost effectiveness of zoledronic acid 5 mg for the management of postmenopausal osteoporosis in women with prior fractures: evidence from Finland, Norway and the Netherlands
- (2011) R. Akehurst et al. JOURNAL OF MEDICAL ECONOMICS
- Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study
- (2010) P. Garnero et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: The FLEX Trial
- (2010) Ann V Schwartz et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Time since prior fracture is a risk modifier for 10-year osteoporotic fractures
- (2010) Lora M Giangregorio et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research
- (2010) Elizabeth Shane et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effect of Osteoporosis Treatment on Mortality: A Meta-Analysis
- (2010) Mark J. Bolland et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Oral bisphosphonates are associated with reduced mortality after hip fracture
- (2010) L. A. Beaupre et al. OSTEOPOROSIS INTERNATIONAL
- Oral bisphosphonates are associated with reduced mortality in frail older people: a prospective five-year study
- (2010) P. N. Sambrook et al. OSTEOPOROSIS INTERNATIONAL
- Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards
- (2010) S. Vasikaran et al. OSTEOPOROSIS INTERNATIONAL
- American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis
- (2010) Jennifer M. Grossman et al. ARTHRITIS CARE & RESEARCH
- Timing of Subsequent Fractures after an Initial Fracture
- (2010) Tineke A. C. M. van Geel et al. Current Osteoporosis Reports
- Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Thirty-six-month results of a randomized, double-blind, controlled trial
- (2009) Kenneth G. Saag et al. ARTHRITIS AND RHEUMATISM
- Hip Fracture Patients at Risk of Second Hip Fracture: A Nationwide Population-Based Cohort Study of 169,145 Cases During 1977–2001
- (2009) Jesper Ryg et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Yearly Zoledronic Acid 5 mg on Bone Turnover Markers and Relation of PINP With Fracture Reduction in Postmenopausal Women With Osteoporosis
- (2009) Pierre D Delmas et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Potential mediators of the mortality reduction with zoledronic acid after hip fracture
- (2009) Cathleen S Colón-Emeric et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy
- (2009) David L Kendler et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial
- (2009) David M Reid et al. LANCET
- Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis
- (2009) I. Imaz et al. OSTEOPOROSIS INTERNATIONAL
- Once-Weekly Risedronate in Men With Osteoporosis: Results of a 2-Year, Placebo-Controlled, Double-Blind, Multicenter Study
- (2008) Steven Boonen et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Severely Suppressed Bone Turnover and Atypical Skeletal Fragility
- (2008) Maja Visekruna et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Vitamin D insufficiency does not affect response of bone mineral density to alendronate
- (2008) D. M. Antoniucci et al. OSTEOPOROSIS INTERNATIONAL
- Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
- (2008) R. G. G. Russell et al. OSTEOPOROSIS INTERNATIONAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started